Could pump therapy offer advantages over conventional insulin delivery during the peri-operative period?

Hammond, Peter
December 2013
Diabetes Digest;2013, Vol. 12 Issue 4, p186
The article presents a retrospective study which evaluates all the surgical procedures of individuals with diabetes in one centre in China over six years. The authors of the study examined the safety and efficacy of continuous subcutaneous insulin infusion (CSII) during the patients' peri-operative care. The CSII group had lower incidence of fever, lower fasting glucose and lower food glucose compared with the control group.


Related Articles

  • Diabetes in the UK -- Luddite or technophile? Kerr, David // Diabetes Digest;2015, Vol. 14 Issue 2, p58 

    The author reflects on the application of technology in the development of the type 1 diabetes care in Great Britain. Topics discussed include the diabetes medical care under the U.S. Patient and Protection Affordable Care Act, the research funding for the development of type 1 diabetes research...

  • Cellnovo launches mobile technology.  // Diabetes Digest;2012, Vol. 11 Issue 1, p48 

    The article reports on the launch of Cellnovo mobile-connected diabetes management system (DMS) and the start of usability trial that would investigate insulin pump technology in people with type 1 diabetes.

  • Treating hypothyroidism in people with type 1 diabetes. Flanagan, Daniel // Diabetes Digest;2014, Vol. 13 Issue 4, p172 

    The article discusses the treatment and management of hypothyroidism in patients with type 1 diabetes as of December 2014. Topics covered include the association of maintaining a thyroid-stimulating hormone (TSH) levels with normal life expectancy and health, and the link of increased...

  • Type 1 Diabetes Mellitus (T1DM) self management in hospital; Is it possible? A literature review. MUNT, REBECCA; HUTTON, ALISON // Contemporary Nurse: A Journal for the Australian Nursing Profess;2012, Vol. 40 Issue 2, p179 

    Aim: To review research evidence on the adults with type 1 diabetes mellitus (T1DM)'s ability to continue self management in the hospital setting. Background: A person with T1DM requires a daily management routine to control glycaemia levels known as self management. On admission to hospital...

  • Young people with diabetes: Better outcomes are needed. Scott, Adrian // Diabetes Digest;2012, Vol. 11 Issue 3, p134 

    The author reflects on National Diabetes Audit Mortality Analysis 2007–2008 which highlighted that there are approximately 2.5 times more deaths in people with T1D in Great Britain as compared with the background with mortality rates, with the excess mortality much greater in young...

  • Medium-Term Effects of Insulin Degludec on Patients with Type 1 Diabetes Mellitus. Nakae, Rie; Kusunoki, Yoshiki; Katsuno, Tomoyuki; Tokuda, Masaru; Akagami, Takafumi; Murai, Kazuki; Hamaguchi, Tomoya; Miyagawa, Jun-ichiro; Namba, Mitsuyoshi // Drugs in R&D;Jun2014, Vol. 14 Issue 2, p133 

    Objective: The aim of this study was to analyze the changes in daily blood glucose fluctuation and insulin dose in patients with type 1 diabetes mellitus (T1DM) undergoing basal-bolus therapy following a switching of basal insulin used from insulin glargine or detemir to insulin degludec....

  • Poor T2D control associated with increased risk of AF.  // Diabetes Digest;2012, Vol. 11 Issue 1, p56 

    The article presents a study on the association between atrial fibrillation (AF) and type 2 diabetes (T2D) in 13 025 people which reveals that HbAm1c level and poor quality glycaemic control are independently linked with AF risk.

  • Results of glycated hemoglobin during treatment with insulin analogues dispensed in the public health system of Federal District in Brazil. Leite, Eliziane Brandão; Pedrosa, Hermelinda Cordeiro; Casulari, Luiz Augusto // Diabetology & Metabolic Syndrome;Aug2015, Vol. 7 Issue 1, p1 

    Background: Diabetes treatment requires specialized multi-professional teams, supplies for blood glucose monitoring and training for self-injections of human insulin or insulin analogues. The State Health Secretariat of the Federal District (SHS-FD) has dispensed insulin analogues by means of...

  • Adherence to Oral Glucose-Lowering Therapies and Associations With 1-Year HbA1c: A Retrospective Cohort Analysis in a Large Primary Care Database. Farmer, Andrew J.; Rodgers, Lauren R.; Lonergan, Mike; Shields, Beverley; Weedon, Michael N.; Donnelly, Louise; Holman, Rury R.; Pearson, Ewan R.; Hattersley, Andrew T.; MASTERMIND Consortium // Diabetes Care;Feb2016, Vol. 39 Issue 2, p258 

    Objective: The impact of taking oral glucose-lowering medicines intermittently, rather than as recommended, is unclear. We conducted a retrospective cohort study using community-acquired U.K. clinical data (Clinical Practice Research Database [CPRD] and GoDARTS database) to examine...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics